Epignostix is a startup based in Germany, most recent round Seed, 1 tracked investor.
Epignostix is a company founded in 2022 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Epignostix is a biotech company developing innovative diagnostic solutions for the early detection of diseases. They focus on highly sensitive and specific diagnostic tests to enable rapid and reliable results.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.